Bridging the Data Divide – Harnessing Synthetic Data for Stronger Real-World Evidence
Childhood obesity affects nearly 20% of U.S. children and adolescents—a staggering 14.7 million youth. Tackling the long-term consequences demands smarter,…
Childhood obesity affects nearly 20% of U.S. children and adolescents—a staggering 14.7 million youth. Tackling the long-term consequences demands smarter,…
Artificial intelligence has reached a pivotal moment, especially in biomedical research. Intelligent systems that act autonomously and coordinate seamlessly hold…
Introduction Medical devices are woven into everyday life, from simple bandages to life-sustaining implants. The U.S. Food and Drug Administration…
A Mounting National Crisis Recent data from the National Institute of Mental Health (NIMH) shows that roughly 57.8 million U.S.…
Obesity is one of the most critical public health challenges of our time. With over 42% of adults in the…
Obesity Is Not an Individual Failure—It Is a Systemic One America’s obesity crisis is not new, but its scale is…
Real-world evidence (RWE) is transforming drug safety by providing critical insights into how medications perform outside of clinical trials. By…
Discover how AI and big data are transforming personalized medicine by integrating genomics, real-world evidence, and clinical data to deliver…
Discover how ICA.ai's RealWorld Insights Engine can be used toleverage community-generated data and advanced analytics to transform disaster response efforts…
When most people think of the Food and Drug Administration (FDA), they likely picture its role in regulating pharmaceuticals. But…